NEW IMPORTANT CLINICAL ADVANCES IN THE MANAGEMENT OF CHEMOTHERAPY INDUCED NEUTROPENIA

Association of Northern California Oncologists

presents a talk for oncologists and oncology nurses entitled

NEW IMPORTANT CLINICAL ADVANCES IN THE MANAGEMENT OF
CHEMOTHERAPY INDUCED NEUTROPENIA
with
Gary Herbert Lyman, M.D., M.P.H.
Professor of Medicine
Duke University School of Medicine

Objectives

Discuss the potential clinical and economic consequences
associated with chemotherapy-induced neutropenia.

Assess the impact of first-cycle neutropenic events.

Review national guideline recommendations for febrile neutropenia (FN)
risk assessment and colony-stimulating factor (CSF) use.

This talk is scheduled for

6:30PM Reception & 7:00PM Dinner/Lecture
December 8th, 2008
Hyatt at Fisherman’s Wharf
555 North Point Street • San Francisco • (415) 563-1234

This meeting is supported by AMGEN. In adherence with PhRMA guidelines, this medical education program is for healthcare professionals only. Inclusion of a healthcare professional’s spouse or other guests is not appropriate.

For directions, please call the meeting locations. FAX your RSVP(s) to José Luis González, ANCO Executive Director, at (415) 472-3961 no later than December 4th.

Download the meeting announcement/registration form at http://www.anco-online.org/Lyman.pdf